# OTREXUP
> **NDA204824** · New Drug Application · Sponsor: ASSERTIO SPECLTY · Approved 2013-10-11
## Drug
- **FDA Application Number:** NDA204824
- **Application type:** New Drug Application
- **Brand name:** OTREXUP
- **Generic name:** METHOTREXATE
- **Active ingredients:** METHOTREXATE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** ASSERTIO SPECLTY
- **Manufacturer:** Antares Pharma, Inc.
- **First approval:** 2013-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204824)
---
*AI Analytics · CC0 1.0*